Galderma, founded in 1981 and headquartered in Switzerland, positions itself as a leader solely dedicated to dermatology, aligning with its slogan, “Advancing dermatology for every skin story.” This strategic focus has enabled the company to construct a robust, innovative, science-based portfolio that spans Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology.
Leveraging trusted partnerships with healthcare professionals, Galderma aims to meet the diverse needs of both consumers and patients, providing superior dermatological outcomes. This consumer-centric approach underscores the company's leadership in the skin health industry.
The company's financial credibility is reinforced by its recent Fr.4.90B secondary market investment on 01 March 2026, led by EQT Group. This significant investment signals strong confidence from the investor community and emphasizes Galderma's strategic potential for growth and innovation in dermatology.